Jun 25, 2025 05:00PM
Jun 18, 2025 05:36PM
Apr 17, 2025 09:39AM
Mar 25, 2025 10:47AM
Mar 10, 2025 11:25AM
Mar 10, 2025 11:18AM
Feb 26, 2025 08:00AM Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board
Dec 27, 2024 04:05PM
Dec 23, 2024 08:00AM
Dec 23, 2024 07:30AM
Dec 17, 2024 08:37AM
Dec 10, 2024 07:30AM
Dec 6, 2024 11:06AM
Dec 3, 2024 07:30AM Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress
Nov 20, 2024 07:30AM
Nov 19, 2024 04:05PM
Nov 12, 2024 04:30PM
Oct 31, 2024 09:30AM
Oct 31, 2024 07:30AM
Oct 25, 2024 09:42AM
Oct 24, 2024 07:00AM Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
Oct 17, 2024 07:00AM
Oct 14, 2024 10:43AM
Oct 4, 2024 04:05PM
Sep 20, 2024 11:20AM
Sep 19, 2024 07:30AM
Sep 16, 2024 09:31AM
Sep 16, 2024 07:30AM Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
Sep 13, 2024 04:30PM
Sep 9, 2024 07:30AM
Sep 6, 2024 07:30AM
Sep 6, 2024 07:30AM
Sep 4, 2024 07:31AM
Sep 4, 2024 07:30AM
Aug 30, 2024 07:00AM Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC
Aug 13, 2024 07:30AM
Jul 31, 2024 04:05PM
Jul 26, 2024 09:30AM
Jul 24, 2024 04:05PM
Apr 16, 2024 11:01AM
Mar 26, 2024 11:06AM
Mar 12, 2024 11:15AM Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study  
Mar 11, 2024 07:00AM
Jan 26, 2024 05:20AM
Jan 25, 2024 06:03PM
Jan 25, 2024 05:17PM
Nov 20, 2023 02:38PM
Oct 30, 2023 11:09AM
Mar 23, 2023 07:00AM Psyence Group Announces Cantheon Capital Private Placement
Mar 21, 2023 07:00AM

327,066 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All